関連する実験動画
Updated: May 5, 2026

09:36
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 17, 2010
30.9K
ホルモン置換療法の開始,中止,継続的な使用に関連した乳房密度の変化
C M Rutter1, M T Mandelson, M B Laya
1Group Health Cooperative of Puget Sound, Center for Health Studies, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA. rutter.c@ghc.org
JAMA
|February 15, 2001
まとめ
ホルモン置換療法 (HRT) の開始は乳房密度を高め,中止は乳房密度を低下させる. 乳腺密度のこれらの動的変化は,閉経後の女性のHRT使用と関連しています.
科学分野:
- 生殖内分泌学 生殖内分泌学
- 腫瘍学 腫瘍学
- 放射線学 放射線学
背景:
- ホルモン補充療法 (HRT) は,乳房の密度を増加させることが知られている.
- 乳房の密度の上昇は,マンモグラフィの感度低下と関連しています.
- HRTの中止と継続が乳房密度に及ぼす影響に関する体系的な研究は欠けている.
研究 の 目的:
- HRTの開始,中止,継続が乳房密度に与える影響を調査する.
- HRTを受ける閉経後の女性の乳房密度の変化を分析する.
- HRTと乳房密度の間のダイナミックな関係に関するデータを提供する.
主な方法:
- 5212人の閉経後の女性を対象とした観察コホート研究.
- 1996年から1998年の間にスクリーニング・マンモグラフィーから収集されたデータ.
- BI-RADSスケールを使用して評価された乳房密度,HRT使用者 (開始者,中止者,継続者) と非使用者を比較する.
主要な成果:
- HRTを開始すると,乳房の密度が著しく増加しました (RR, 2.57).
- HRTの中止は乳房密度の低下と関連していた (RR,1.81).
- HRTの継続的な使用は,増加した密度 (RR, 1.33) と持続的な高密度 (RR, 1.45) を示した.
結論:
- HRTに関連する乳房密度の変化は,動的である.
- HRTを開始すると,乳房の密度が増加します.
- HRTを中止すると,乳房の密度が低下します.
関連する概念動画
Bone Remodeling
34.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
34.4K
Bone Disorders
8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Target Cell Response to Hormones
5.6K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.6K
Hormonal Regulation of the Menstrual Cycle
2.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K
Menopause
5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Cellular Adaptation III: Hyperplasia
55
Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
55

